Scan beyond Perdoceo Education's earnings beat and evaluate other financially solid operators with potential for steady compounding in our curated list of 32 resilient stocks with low risk scores.
For a shareholder in Perdoceo Education, the core belief is that health sciences, technology enabled enrollment, and corporate partnerships can keep supporting earnings and cash generation. The third quarter update, with higher revenue and net income versus a year ago, broadly fits that story. The near term swing factor still looks like execution on health sciences programs and corporate relationships, rather than one quarter of results.
The most immediate risk remains operational and legal complexity. Integrating South University, managing clinical capacity, and handling CTU legal expenses could pull on margins and restrict how much cash is available for buybacks, dividends, or deals. The latest earnings beat helps confidence but does not remove those execution and regulatory pressures.
The third quarter and nine month 2026 earnings announcement is the key update tying into these catalysts. Revenue of US$215.86 million for the quarter and US$650.96 million year to date, alongside higher net income and earnings per share than the prior year periods, show the existing portfolio still producing. That mattering for investors is about consistency rather than a single data point.
Those figures sit against the longer term push into licensure focused health sciences and AI supported student acquisition. If South University is added as planned and University of St. Augustine maintains operational strength, the current earnings base provides a financial buffer during integration. Any rise in student acquisition costs or legal outlays would test how resilient Perdoceo Education's cash generation really is against its growth and capital return ambitions.
Perdoceo Education's consensus story is fairly simple. Analysts see a slow build in revenue, some lift in profitability, and a higher earnings base a few years out, rather than a sharp reset. For an investor tracking this over multiple quarters, the interest is less about a single beat and more about whether the company keeps edging closer to those targets.
The revenue line in the model grows at 1.6% a year over the next three years. That is a modest pace, especially for a business leaning into health sciences and technology supported enrollment, and it leaves most of the heavy lifting to margin improvement and capital allocation. The assumption that profit margins move from 20.6% today to 24.1% in three years indicates that analysts are counting on South University integration, licensure programs, and AI supported marketing to show up in operating efficiency.
Earnings expectations do the rest of the work. Analysts are looking for profits of US$217.1 million by about 2029, compared with US$177.1 million today. That is an earnings increase of roughly US$40 million over the period. It ties back directly to the thesis that higher margin health sciences programs, lower share count, and steady student demand can support a thicker layer of net income on top of relatively gentle revenue growth.
Perdoceo Education is also modeled with fewer shares on issue over time, with analysts assuming the share count declines by 2.71% per year for the next three years. That matters because even if earnings grow gradually in absolute dollars, a shrinking base of shares can lift earnings per share and influence how investors think about total return potential. It connects the cash generation debate straight to future per share metrics.
On valuation, the consensus view connects those fundamentals to a specific outcome. To line up with the current analyst framework, an investor would need to assume that by 2029 revenue reaches US$899.2 million, earnings sit at US$217.1 million, and the shares trade on a P/E of 14.4x. That compares with a P/E of 11.1x today and an industry P/E reference point of 12.9x for US Consumer Services, so the scenario includes both higher earnings and a richer multiple than the present.
The discount rate in the Simply Wall St model sits at 7.24%, very close to the 7.2% figure used in the price target example. That rate is what links the future earnings and revenue path back to a present value, including the analysts' US$44.0 price target versus the current US$31.54 share price. The gap of 28.3% between those two prices reflects how much weight the model gives to successful execution on margins, share reductions, and the 2029 earnings objective.
Perdoceo Education's narrative projects US$899.2 million revenue and US$217.1 million earnings by 2029. This assumes 1.6% yearly revenue growth and an earnings increase of around US$40 million from US$177.1 million today.
Uncover how Perdoceo Education's fair value indicates a 66% potential upside to its current price, before enthusiasm around Perdoceo Education's outlook closes that gap.
Four fair value estimates from the Simply Wall St Community span from US$25 to about US$105, a very wide spread that flags sharply different views on Perdoceo Education. Before the latest earnings update, some members focused on cash, health sciences expansion, and AI tools as potential supports, while others highlighted integration costs and legal exposure. You can use that range to stress test your own assumptions and compare several alternative viewpoints.
Explore 3 other Perdoceo Education fair value estimates, including one that suggests as much as 6% downside from the current price.
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so consider your own research and judgment.
If the Perdoceo Education story has sharpened your thinking about quality, risk, and payout potential, use that same lens across a wider watchlist. The Simply Wall St Screener lets you filter the market by balance sheet strength, income potential, and mispriced quality so you can build a shortlist that fits your own risk and return preferences.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com